Northwestern Medicine | Strategic Alliance Partners

Latest from Northwestern Medicine


Understanding Further Treatment Opportunities for Patients With Polycythemia Vera

December 07, 2020

Pharmacy Times® interviewed Brady Stein, MD, MHSc, of the Feinberg School of Medicine at Northwestern University, on the implications of the results of his research on further investigation and treatment opportunities for patients with polycythemia vera.

Understanding Causes of Death of Patients With Polycythemia Vera

December 07, 2020

Pharmacy Times® interviewed Brady Stein, MD, MHSc, of the Feinberg School of Medicine at Northwestern University, on the noteworthy results observed in the study in relation to cause of death among patients with polycythemia vera.

Investigating Prior Data on the Causes of Death for Patients With Polycythemia Vera

December 07, 2020

Pharmacy Times® interviewed Brady Stein, MD, MHSc, of the Feinberg School of Medicine at Northwestern University, on the issues existing around prior data on the causes of death for patients with polycythemia vera (PV) and why it was important to have greater clarity in this area.

Survival Estimates and Mortality Rates Among Patients With Polycythemia Vera

December 06, 2020

Pharmacy Times® interviewed Brady Stein, MD, MHSc, of the Feinberg School of Medicine at Northwestern University, on the survival estimates for patients with polycythemia vera in the past and the mortality rates among these patients.

Mortality and Causes of Death in Patients With Polycythemia Vera

December 06, 2020

Pharmacy Times® interviewed Brady Stein, MD, MHSc, of the Feinberg School of Medicine at Northwestern University, on what polycythemia vera (PV) is and why it was important to understand mortality and causes of death among patients with PV.